Diagnosis and Treatment of Lichen Sclerosus
Top Cited Papers
Open Access
- 14 December 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in American Journal of Clinical Dermatology
- Vol. 14 (1), 27-47
- https://doi.org/10.1007/s40257-012-0006-4
Abstract
Lichen sclerosus (LS) is a chronic, inflammatory, mucocutaneous disorder of genital and extragenital skin. LS is a debilitating disease, causing itch, pain, dysuria and restriction of micturition, dyspareunia, and significant sexual dysfunction in women and men. Many findings obtained in recent years point more and more towards an autoimmune-induced disease in genetically predisposed patients and further away from an important impact of hormonal factors. Preceding infections may play a provocative part. The role for Borrelia is still controversial. Trauma and an occlusive moist environment may act as precipitating factors. Potent and ultrapotent topical corticosteroids still head the therapeutic armamentarium. Topical calcineurin inhibitors are discussed as alternatives in the treatment of LS in patients who have failed therapy with ultrapotent corticosteroids, or who have a contraindication for the use of corticosteroids. Topical and systemic retinoids may be useful in selected cases. Phototherapy for extragenital LS and photodynamic therapy for genital LS may be therapeutic options in rare cases refractory to the already mentioned treatment. Surgery is restricted to scarring processes leading to functional impairment. In men, circumcision is effective in the majority of cases, but recurrences are well described. Anogenital LS is associated with an increased risk for squamous cell carcinoma of the vulva or penis. This review updates the epidemiology, clinical presentation, histopathology, pathogenesis, and management of LS of the female and male genitals and extragenital LS in adults and children.Keywords
This publication has 155 references indexed in Scilit:
- Lichen Sclerosus: Epidemiological Distribution in an Equal Access Health Care SystemJournal of Urology, 2011
- A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosusJournal of the American Academy of Dermatology, 2011
- Epstein-Barr Virus and Human Papillomavirus Infection in Vulvar Lichen SclerosusJournal of Lower Genital Tract Disease, 2010
- Efficacy of Photodynamic Therapy in Vulvar Lichen Sclerosus Treatment Based on Immunohistochemical Analysis of CD34, CD44, Myelin Basic Protein, and Ki67 AntibodiesInternational Journal of Gynecologic Cancer, 2010
- Long‐term management of vulval lichen sclerosus in adult womenAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- Psoralen–UVA treatment for generalized prepubertal extragenital lichen sclerosus et atrophicusJournal of the American Academy of Dermatology, 2006
- Infantile perineal protrusionJournal of the American Academy of Dermatology, 2006
- Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: A double-blind, placebo-controlled studyJournal of the American Academy of Dermatology, 1994
- Neuroborreliosis in morphea and lichen sclerosus et atrophicusJournal of the American Academy of Dermatology, 1988
- Serum Levels of Sex Hormones in Vulvar Lichen Sclerosus, and the Effect of Topical TestosteroneNew England Journal of Medicine, 1984